Mesothelin‑specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3‑treated self‑differentiated dendritic cells
Author(s) -
Niphat Jirapongwattana,
Suyanee Thongchot,
Wannasiri Chiraphapphaiboon,
Thaweesak Chieochansin,
Doonyapat Sa-nguanraksa,
Malee Warnnissorn,
Peti Thuwajit,
Pathai Yenchitsomanus,
Chanitra Thuwajit
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8338
Subject(s) - mesothelin , cancer research , triple negative breast cancer , cancer cell , biology , cancer , immunology , medicine , breast cancer , antigen
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom